Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Bone mineral density and L-thyroxine treatment in rapidly cycling bipolar disorder.

Gyulai L, Jaggi J, Bauer MS, Younkin S, Rubin L, Attie M, Whybrow PC.

Biol Psychiatry. 1997 Feb 15;41(4):503-6. No abstract available.

PMID:
9034547
[PubMed - indexed for MEDLINE]
2.

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.

Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC.

J Affect Disord. 2004 Dec;83(2-3):183-90.

PMID:
15555712
[PubMed - indexed for MEDLINE]
3.

Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation.

Gyulai L, Bauer M, Garcia-Espana F, Hierholzer J, Baumgartner A, Berghöfer A, Whybrow PC.

J Affect Disord. 2001 Oct;66(2-3):185-91.

PMID:
11578671
[PubMed - indexed for MEDLINE]
4.

Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.

Heijckmann AC, Huijberts MS, Geusens P, de Vries J, Menheere PP, Wolffenbuttel BH.

Eur J Endocrinol. 2005 Jul;153(1):23-9.

PMID:
15994742
[PubMed - indexed for MEDLINE]
Free Article
5.

L-thyroxine for rapid-cycling bipolar illness.

Leibow D.

Am J Psychiatry. 1983 Sep;140(9):1255. No abstract available.

PMID:
6614242
[PubMed - indexed for MEDLINE]
6.

Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.

Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmartí A.

Endocr Relat Cancer. 2005 Dec;12(4):973-81.

PMID:
16322336
[PubMed - indexed for MEDLINE]
Free Article
7.

High doses of levothyroxine for refractory rapid cycling.

Extein IL.

Am J Psychiatry. 2000 Oct;157(10):1704-5. No abstract available.

PMID:
11007733
[PubMed - indexed for MEDLINE]
8.

Timing of menopause, reproductive years, and bone mineral density: a cross-sectional study of postmenopausal Japanese women.

Osei-Hyiaman D, Satoshi T, Ueji M, Hideto T, Kano K.

Am J Epidemiol. 1998 Dec 1;148(11):1055-61.

PMID:
9850127
[PubMed - indexed for MEDLINE]
Free Article
9.

Diagnosis and treatment of rapidly cycling bipolar disorder.

Maj M.

Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 2:II62-5.

PMID:
11824840
[PubMed - indexed for MEDLINE]
10.

High-dose T4 for rapid-cycling bipolar disorder.

Weeston TF, Constantino J.

J Am Acad Child Adolesc Psychiatry. 1996 Feb;35(2):131-2. No abstract available.

PMID:
8720620
[PubMed - indexed for MEDLINE]
11.

Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size.

Baldini M, Gallazzi M, Orsatti A, Fossati S, Leonardi P, Cantalamessa L.

J Intern Med. 2002 May;251(5):407-14.

PMID:
11982740
[PubMed - indexed for MEDLINE]
12.

Ultradistal and distal forearm bone mineral density in postmenopausal women.

Jou HJ, Yeh PS, Wu SC, Lu YM.

Int J Gynaecol Obstet. 2003 Aug;82(2):199-205.

PMID:
12873781
[PubMed - indexed for MEDLINE]
13.

Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy.

Nuzzo V, Lupoli G, Esposito Del Puente A, Rampone E, Carpinelli A, Del Puente AE, Oriente P.

Gynecol Endocrinol. 1998 Oct;12(5):333-7.

PMID:
9859026
[PubMed - indexed for MEDLINE]
14.

[Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases].

Afflelou S, Auriacombe M, Cazenave M, Chartres JP, Tignol J.

Encephale. 1997 May-Jun;23(3):209-17. Review. French.

PMID:
9333552
[PubMed - indexed for MEDLINE]
15.

[Prolonged suppressive L-thyroxine therapy. Longitudinal study of the effect of LT4 on bone mineral density and bone metabolism markers in 71 patients].

Rachedi F, Rohmer V, Six P, Duquenne M, Wion Barbot N, Minebois A, Bigorgne JC, Audran M.

Presse Med. 1999 Feb 20;28(7):323-9. French.

PMID:
10083873
[PubMed - indexed for MEDLINE]
16.

L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.

La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE.

Minerva Ginecol. 2008 Dec;60(6):475-84.

PMID:
18981975
[PubMed - indexed for MEDLINE]
17.

Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study.

Svare A, Nilsen TI, Bjøro T, Forsmo S, Schei B, Langhammer A.

Eur J Endocrinol. 2009 Nov;161(5):779-86. doi: 10.1530/EJE-09-0139. Epub 2009 Aug 11.

PMID:
19671706
[PubMed - indexed for MEDLINE]
Free Article
18.

L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism.

Pines A, Dotan I, Tabori U, Villa Y, Mijatovic V, Levo Y, Ayalon D.

Gynecol Endocrinol. 1999 Jun;13(3):196-201.

PMID:
10451812
[PubMed - indexed for MEDLINE]
19.

Tryptophan for treatment of rapid-cycling bipolar disorder comorbid with fibromyalgia.

Sharma V, Barrett C.

Can J Psychiatry. 2001 Jun;46(5):452-3. No abstract available.

PMID:
11441787
[PubMed - indexed for MEDLINE]
20.

[Evaluation of bone density in women after thyroid cancer surgery and treatment with suppressive doses of L-thyroxine].

Jurecka-Tuleja B, August R, Kukulska A, Bartnikowa W, Deja R, Czernik E, Handkiewicz-Junak D.

Wiad Lek. 2001;54 Suppl 1:378-82. Polish.

PMID:
12182053
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk